Company HBL - Hadasit Bio-Holdings Ltd TEL AVIV STOCK EXCHANGE
Equities
HDST
IL0010954050
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 19/09/15 |
Tamar Raz
CHM | Chairman | 60 | 17/05/14 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 30/08/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 28/07/18 |
Erez Meltzer
BRD | Director/Board Member | 66 | 04/07/16 |
Orit Stav
BRD | Director/Board Member | 53 | 31/10/17 |
Tamar Raz
CHM | Chairman | 60 | 17/05/14 |
Merav Kaye
BRD | Director/Board Member | 50 | 27/09/14 |
Asher Elhayany
BRD | Director/Board Member | 71 | 25/12/22 |
Director/Board Member | 58 | 17/07/21 | |
Yuval Adar
BRD | Director/Board Member | 52 | 18/07/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,088,522 | 2,772,493 ( 25.00 %) | 0 | 25.00 % |
Company contact information
HBL- Hadasit Bio-Holdings Ltd.
Jerusaelm Bio-Park Hadassah Ein-Kerem Campus
91120, Jerusalem
+
http://www.hbl.co.ilSector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |